BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference

  PepGen Inc. announced that it will be presenting at upcoming medical meetings and an investor conference.

  September 1, 2023

   · 

  5 min read
• Business

  Karyopharm Appoints Zhen Su, MD, MBA to its Board of Directors

  Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of Zhen Su, MD, MBA, to its Board of Directors, effective August 31, 2023.

  September 1, 2023

   · 

  7 min read
• Business

  Immix Biopharma Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at NY Presbyterian Hospital in NY, Joins Scientific Advisory Board

  Immix Biopharma, Inc., a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, announced that effective , Dr. Suzanne Lentzsch has joined the Nexcella Scientific Advisory Board.

  September 1, 2023

   · 

  7 min read
• Deals

  Globus Medical Completes Merger with NuVasive

  Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with NuVasive, Inc.

  September 1, 2023

   · 

  7 min read
• MustGrow Announces Grant of RSUs and DSUs

  MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”), today announced that the board of directors of the Company authorized and approved

  September 1, 2023

   · 

  2 min read
• Biotech Beach

  IPF Has A 0% Survival Rate Without Lung Transplant And A Median Survival Time Of 2-5 Years From Diagnosis - Could GRI-0621 Be The Solution?

  Idiopathic Pulmonary Fibrosis (IPF) is a serious chronic lung disease characterized by the thickening and stiffening of the lung tissue surrounding the air sacs.

  September 1, 2023

   · 

  3 min read
• Business

  Leslie McDonnell joins Mölnlycke’s Board of Directors

  Leslie McDonnell has more than 20 years of experience in the Medtech industry through executive leadership roles at Medtronic, 3M Healthcare, and Natus Medical.

  September 1, 2023

   · 

  1 min read
• Business

  Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

  Hansa Biopharma, “Hansa”, a pioneer in enzyme technology for rare immunological conditions, announced that Dr. Hitto Kaufmann has been appointed as Hansa’s Chief Scientific Officer effective 1 December 2023.

  September 1, 2023

   · 

  4 min read
• Hugel resubmits BLA for its botulinum toxin, Letybo to the U.S. FDA

  Hugel, a global total medical aesthetics company, announced that the company resubmitted the BLA for its botulinum toxin, Letybo (letibotulinumtoxinA) on August 31st (local time), for the indication of glabellar (frown) lines to the U.S. FDA.

  September 1, 2023

   · 

  1 min read
• Genetown

  Repligen Corporation to Present at Wells Fargo Healthcare Conference

  Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it will be presenting at the Wells Fargo Healthcare Conference being held September 6 -8 in Boston.

  September 1, 2023

   · 

  1 min read